<!doctype html>
<html lang="en">
  <head>
    <!-- Required meta tags -->
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <!-- Global site tag (gtag.js) - Google Analytics -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=UA-214183933-1"></script>
    <script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'UA-214183933-1');
    </script>

    <!-- Bootstrap CSS -->
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.1.3/dist/css/bootstrap.min.css" rel="stylesheet" integrity="sha384-1BmE4kWBq78iYhFldvKuhfTAU6auU8tT94WrHftjDbrCEXSU1oBoqyl2QvZ6jIW3" crossorigin="anonymous">

    <style type="text/css">
      table {
        font-size: small;
      }
      a {
        color: grey;
      }
      a:link {
        text-decoration: none;
      }
      a:hover {
        text-decoration: underline;
      }
      p {
        text-align: justify;
      }
      th {white-space: nowrap;}
      td:nth-child(2)  {white-space: nowrap;}

      /* styling buttons */
      .show-more-btn {
        margin-bottom: 15px;
        cursor: pointer;
        color: #0095e5;
        white-space: nowrap;
        transition: color 300ms ease-in-out;
        border: 0;
        font-size: small;
        background: transparent;
      }
      .show-more-btn:hover {
        color: red;
      }
      .hidden {
        display: none;
      }
    </style>
    <script src="https://cdn.jsdelivr.net/gh/tomik23/show-more@1.1.2/dist/js/showMore.min.js"></script>

    <script type="text/javascript">
      document.addEventListener('DOMContentLoaded', function () {
        // text, table, list, elelemnts
        new ShowMore('.element', {
          onMoreLess: (type, object) => {
            // type = less/more and full object
            console.log(type, object);
          },
        });
      });
    </script>
      <title>Alcon | Brayniac</title>
    </head>
    <body>
    <div class="container justify-content-center mt-5">
      <div class="col-xxl-8 col-xl-10 col-md-12 mx-auto">
        <div class="row border-bottom mb-4 pb-4">
          <h1 class="mb-5">Alcon</h1>
          <p>
            Brayniac read 40 webpages from <a href="https://www.alcon.com/newsroom">https://www.alcon.com/newsroom</a>. This content is about 103 pages long.
          </p>
          <p>
            Brayniac generated a list of keywords on the left and corresponding blurbs on the right. The keywords are ranked by importance. The most important keyword appears at the top. As you scroll down, the keyword importance decreases.
          </p>
          <p>
            The blurb include an actual usage of the keyword from the webpages. It also provides a breakdown of which posts and how many times the keyword appeared in those posts.
          </p>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>IOL</h3></div>
          <div class="col-9">
            <p> Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced AcrySof ® IQ PanOptix ® Trifocal Intraocular Lens (IOL) has surpassed more than one million implants worldwide. 2</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-22</th>
                  <td>8 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/panoptix-trifocal-iol-surpasses-one-million-implants-worldwide">PanOptix Trifocal IOL Surpasses One Million Implants Worldwide | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>16 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>37 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-16</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/ora-system-first-and-only-database-real-time-iol-calculations-during-cataract-surgery">ORA System – the First and Only Database for Real-Time IOL Calculations during Cataract Surgery – Reaches 2 Million Cases | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-20</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-proud-partner-uk-rcophth-national-ophthalmology-database">Alcon Proud Partner of UK RCOphth National Ophthalmology Database; Data Highlights Benefits of Specific AcrySof Models | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>25 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>IFRS</h3></div>
          <div class="col-9">
            <p>Core results, such as core operating margin and core EPS, are non-IFRS measures. For additional information, including a reconciliation of such core results to the most directly comparable measures presented in accordance with IFRS, see the explanation of non-IFRS measures and reconciliation tables in the 'Non-IFRS measures as defined by the Company' and 'Financial tables' sections.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>14 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>12 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>14 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>13 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>14 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>.q4default</h3></div>
          <div class="col-9">
            <p> .q4default .bwalignc</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>14 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>8 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>11 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>7 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>13 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>US</h3></div>
          <div class="col-9">
            <p>53 LR GENEVA--(BUSINESS WIRE)--
Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the fourth quarter and full year ended December 31, 2021.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>6 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>8 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>11 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>9 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>10 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>ASCRS</h3></div>
          <div class="col-9">
            <p>Texas--(BUSINESS WIRE)--
Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people See Brilliantly, will present a breadth of data during the American Society of Cataract and Refractive Surgery (ASCRS) 2021 annual meeting, taking place July 23-27 in Las Vegas. More than 60 abstracts featuring Alcon ophthalmic products and equipment will be presented, reinforcing the Company’s industry-leading portfolio.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>16 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>AcrySof</h3></div>
          <div class="col-9">
            <p> Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced AcrySof ® IQ PanOptix ® Trifocal Intraocular Lens (IOL) has surpassed more than one million implants worldwide. 2</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-22</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/panoptix-trifocal-iol-surpasses-one-million-implants-worldwide">PanOptix Trifocal IOL Surpasses One Million Implants Worldwide | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>10 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-20</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-proud-partner-uk-rcophth-national-ophthalmology-database">Alcon Proud Partner of UK RCOphth National Ophthalmology Database; Data Highlights Benefits of Specific AcrySof Models | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>8 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>general & administration</h3></div>
          <div class="col-9">
            <p>875 4,652 2,940 Selling, general & administration (813 ) (737 ) (3,076 ) (2,694 ) Research & development (180 ) (155 ) (842 )</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>7 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Company</h3></div>
          <div class="col-9">
            <p>Proposed dividend The Company's Board of Directors proposed a dividend of CHF 0.20 per share, based on 2021 financial results. The Company's shareholders will vote on this proposal at the 2022 Annual General Meeting on April 27, 2022.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>8 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>ORA</h3></div>
          <div class="col-9">
            <p> Alcon, the global leader in eye care, today announced its Optiwave Refractive Analysis (ORA) SYSTEM®, the only intraoperative aberrometer on the market, has reached two million cases worldwide. This milestone signifies an important leap forward in cataract surgery by delivering even greater accuracy than preoperative calculation methods alone.
 </p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-06-16</th>
                  <td>13 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/ora-system-first-and-only-database-real-time-iol-calculations-during-cataract-surgery">ORA System – the First and Only Database for Real-Time IOL Calculations during Cataract Surgery – Reaches 2 Million Cases | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Las Vegas</h3></div>
          <div class="col-9">
            <p>Texas--(BUSINESS WIRE)--
Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people See Brilliantly, will present a breadth of data during the American Society of Cataract and Refractive Surgery (ASCRS) 2021 annual meeting, taking place July 23-27 in Las Vegas. More than 60 abstracts featuring Alcon ophthalmic products and equipment will be presented, reinforcing the Company’s industry-leading portfolio.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>13 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Novartis</h3></div>
          <div class="col-9">
            <p>In particular, our expectations could be affected by uncertainties regarding the success of our separation and spin-off from Novartis. Should one or more of these uncertainties or risks materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-debuts-dailies-total1-astigmatism-other-eye-care-innovations-title-sponsor-seco">Alcon Debuts DAILIES TOTAL1 for Astigmatism, Other Eye Care Innovations as Title Sponsor of SECO 2022 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-academy21-program-showcase-total30-other-innovations-meet-critical-patient-and">Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-14</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-celebrates-world-sight-day-2021-communities-worldwide-programs-improved-access">Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>8 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>4:30-6:30 p.m. ET</h3></div>
          <div class="col-9">
            <p>Presented by Dr. Holly Lorentz, 4:30-6:30 p.m. ET. Poster Presentation :</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-11-01</th>
                  <td>12 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-academy21-program-showcase-total30-other-innovations-meet-critical-patient-and">Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>NV</h3></div>
          <div class="col-9">
            <p>ASCRS, Las Vegas, NV. 25 July 2021.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>11 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Research & development</h3></div>
          <div class="col-9">
            <p>Research & development (180 ) (155 ) (842 ) (673 )</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>MIGS</h3></div>
          <div class="col-9">
            <p>{ text-decoration: underline } Alcon will leverage its global footprint and leadership in ophthalmology to drive future growth, bringing this innovative device to more patients worldwide Ivantis associates, including manufacturing and sales, are immediately integrated into Alcon to ensure continuity for new and existing customers Differentiated five-year data demonstrating clinical impact will be showcased at 2022 medical meetings GENEVA--(BUSINESS WIRE)--
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the closing of its previously announced acquisition of Ivantis ® , developer of the novel Hydrus ® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients in connection with cataract surgery. *</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>8 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>U.S.</h3></div>
          <div class="col-9">
            <p>The Foundation oversees and directs activities in the U.S. for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries and Africa. The Prix Galien was created in 1970 by Roland Mehl in honor of Galien, the father of medical science and modern pharmacology.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-22</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/panoptix-trifocal-iol-surpasses-one-million-implants-worldwide">PanOptix Trifocal IOL Surpasses One Million Implants Worldwide | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-debuts-dailies-total1-astigmatism-other-eye-care-innovations-title-sponsor-seco">Alcon Debuts DAILIES TOTAL1 for Astigmatism, Other Eye Care Innovations as Title Sponsor of SECO 2022 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-dozen-scientific-presentations-unique-water-surface-contact-lens">Alcon to Showcase a Dozen Scientific Presentations on Unique Water Surface Contact Lens Technologies at #Academy21 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-academy21-program-showcase-total30-other-innovations-meet-critical-patient-and">Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-14</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-celebrates-world-sight-day-2021-communities-worldwide-programs-improved-access">Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-09-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-honored-futureedge-50-award">Alcon Honored with FutureEdge 50 Award | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/new-alcon-data-contact-lens-dry-eye-and-ocular-health-innovations-be-presented">New Alcon Data on Contact Lens, Dry Eye and Ocular Health Innovations to Be Presented at #ARVO2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-systane-hydration-multi-dose-preservative-free-lubricant-eye-drops-us">Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>6 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcons-systane-hydration-preservative-free-lubricant-eye-drop-voted-product-of-year">Alcon’s SYSTANE Hydration Preservative Free Lubricant Eye Drop Voted by Consumers as Eye Care “Product of the Year” | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>6 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>9 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>AGM</h3></div>
          <div class="col-9">
            <p>WIRE)--
Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on April 27, 2022. Due to the continuing tense situation due to the COVID-19 pandemic, and as a precautionary and prudent measure, Alcon’s Board of Directors decided to hold the AGM in a closed format without the personal attendance of shareholders as permitted by Swiss ordinance and for the safety of Alcon’s shareholders and associates.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>MD</h3></div>
          <div class="col-9">
            <p>“As one of the investigators for the Clareon pivotal trial, I was immediately impressed with the clarity of the new IOL material, delivery system and the consistent refractive outcomes,” said Dr. Samuel H. Lee, MD, Ophthalmologist, Sacramento, CA. *</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>10 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-retina-fellows-institute-brings-together-world-class-ophthalmology-leaders">Alcon Retina Fellows Institute Brings Together World-Class Ophthalmology Leaders to Train Next Generation of Retina Surgeons | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Vivity</h3></div>
          <div class="col-9">
            <p>Implantables growth reflected market improvements and ongoing adoption of advanced technology intraocular lenses, led by the launch of Vivity . Consumables growth primarily reflected market improvements.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>6 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Astigmatism</h3></div>
          <div class="col-9">
            <p>Alcon officially launched DAILIES TOTAL1® for Astigmatism during SECO 2022 with a large in-booth presence, an exclusive bespoke event for ECPs, convention center signage, social media presence and more. The company&rsquor;s robust program featured the introduction of SYSTANE® COMPLETE Preservative-Free (PF) Lubricant Eye Drops and the latest research that supports Alcon&rsquor;s contact lens, dry eye and ocular health portfolios.
 </p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-11</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-debuts-dailies-total1-astigmatism-other-eye-care-innovations-title-sponsor-seco">Alcon Debuts DAILIES TOTAL1 for Astigmatism, Other Eye Care Innovations as Title Sponsor of SECO 2022 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-academy21-program-showcase-total30-other-innovations-meet-critical-patient-and">Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Simbrinza</h3></div>
          <div class="col-9">
            <p>Growth in ocular health was led by strong demand for our brand family of Systane artificial tear products, as well as the addition of Simbrinza glaucoma eye drops . For the full year 2021, Vision Care net sales increased 15%, or 14% on a constant currency basis, compared to 2020.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>the Board of Directors</h3></div>
          <div class="col-9">
            <p>Discharge of the members of the Board of Directors and the members of the Executive Committee 3. Appropriation of earnings and declaration of dividend as per the balance sheet of Alcon Inc. of December 31, 2021 ▪</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>PMID</h3></div>
          <div class="col-9">
            <p>PMID: 33907378; PMCID: PMC8068507.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>7 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Fort Worth</h3></div>
          <div class="col-9">
            <p>+ 1 817 615 2789 (Fort Worth) [email protected] Media Relations</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-09-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-honored-futureedge-50-award">Alcon Honored with FutureEdge 50 Award | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-systane-hydration-multi-dose-preservative-free-lubricant-eye-drops-us">Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-12</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-host-virtual-capital-markets-day-march-24">Alcon to Host Virtual Capital Markets Day on March 24 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Switzerland</h3></div>
          <div class="col-9">
            <p>If approved by the shareholders, a dividend of CHF 0.20 in cash per share will be payable with the record date expected to be May 2, 2022 and the payout date in Switzerland expected to be on or around May 5, 2022. The Swiss withholding tax of 35% will be deducted from the gross dividend amount.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-21</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-again-recognised-top-employer-2022-europe-brazil">Alcon Again Recognised as Top Employer 2022 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-recognised-top-employer-2021-europe-brazil">Alcon Recognised as Top Employer 2021 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Systane</h3></div>
          <div class="col-9">
            <p>SiHy contact lenses and Systane drive above-market growth in Vision Care Vision Care net sales of $0.9 billion, which include contact lenses and ocular health, increased 10%, or 12% on a constant currency basis, compared to the fourth quarter of 2020. Contact lens sales benefited from growth in silicone hydrogel (SiHy)</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-01</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-academy21-program-showcase-total30-other-innovations-meet-critical-patient-and">Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/new-alcon-data-contact-lens-dry-eye-and-ocular-health-innovations-be-presented">New Alcon Data on Contact Lens, Dry Eye and Ocular Health Innovations to Be Presented at #ARVO2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-systane-hydration-multi-dose-preservative-free-lubricant-eye-drops-us">Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Top Employers Institute</h3></div>
          <div class="col-9">
            <p>Each year, Top Employers Institute certifies organisations who are focused on putting their people first through their exceptional Human Resources (HR) policies. The Top Employers Institute programme certifies organisations based on the participation and results of their HR Best Practices Survey.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-21</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-again-recognised-top-employer-2022-europe-brazil">Alcon Again Recognised as Top Employer 2022 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-27</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-recognised-top-employer-2021-europe-brazil">Alcon Recognised as Top Employer 2021 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Alcon Inc.</h3></div>
          <div class="col-9">
            <p>Approval of the operating and financial review of Alcon Inc., the annual financial statements of Alcon Inc. and the consolidated financial statements for 2021 2. Discharge of the members of the Board of Directors and the members of the Executive Committee 3.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Precision1</h3></div>
          <div class="col-9">
            <p>contact lenses, including Precision1, Precision1 for Astigmatism and Dailies Total1 , and continuing recovery in international markets. Growth in ocular health was led by strong demand for our brand family of Systane artificial tear products, as well as the addition of Simbrinza glaucoma eye drops .</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Vision Care</h3></div>
          <div class="col-9">
            <p>Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 24,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-22</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/panoptix-trifocal-iol-surpasses-one-million-implants-worldwide">PanOptix Trifocal IOL Surpasses One Million Implants Worldwide | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-academy21-program-showcase-total30-other-innovations-meet-critical-patient-and">Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-09-03</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/optometry-reference-guide-creates-new-category-alcons-permanent-water-surface-lenses">Optometry Reference Guide Creates New Category for Alcon’s Permanent Water Surface Lenses | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Australia</h3></div>
          <div class="col-9">
            <p>{ text-decoration: underline } Clinically proven to relieve all types of dry eye, 1 Systane Complete is now preservative-free and available in a multi-dose bottle Joins the fast-growing, preservative-free segment of artificial tears, representing over 40% of the global category 2 Additional market launches, including the U.S. and Australia, planned to follow in early 2022</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Alcon's Investor Relations</h3></div>
          <div class="col-9">
            <p>The webcast can be accessed online through Alcon's Investor Relations website, investor.alcon.com . Listeners should log on approximately 10 minutes in advance.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Loss)/income</h3></div>
          <div class="col-9">
            <p>(29 ) 789 (Loss)/income before taxes (635 ) 1,021 167 217 49 (154 )</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>the Executive Committee</h3></div>
          <div class="col-9">
            <p>Discharge of the members of the Board of Directors and the members of the Executive Committee 3. Appropriation of earnings and declaration of dividend as per the balance sheet of Alcon Inc. of December 31, 2021 ▪</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>ARGOS</h3></div>
          <div class="col-9">
            <p>CEST Moderated by Professor Dr. Gerd Auffarth from Germany, he will be joined by Professor Rudy Nuijts from the Netherlands, Dr. Edoardo Ligabue from Italy, Dr. Ertan Sunay from Turkey and Dr. Norbert Pesztenlehrer from Hungary to discuss innovative approaches to presbyopia correction with AcrySof ® IQ Vivity TM , choosing the right advanced technology IOLs, and using the ARGOS ® Biometer as a smart planning solution. Of the 41 abstracts to be presented, more than half will focus on Alcon’s market-leading intraocular lens technologies, including AcrySof IQ Vivity and PanOptix ® IOLs.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>6 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-16</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/ora-system-first-and-only-database-real-time-iol-calculations-during-cataract-surgery">ORA System – the First and Only Database for Real-Time IOL Calculations during Cataract Surgery – Reaches 2 Million Cases | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Europe</h3></div>
          <div class="col-9">
            <p>And to yet again be recognised as a Top Employer in Europe and Brazil, in addition to several Great or Best Places to Work Awards in Asia Pacific (APAC), is an honour for which our associates can be proud.”
  Top Employers Institute CEO David Plink says, “Reflecting on the demanding year that has, like the year before it, impacted organisations across the world, Alcon has continued to show that it prioritises maintaining excellent people practices in their workplace.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-21</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-again-recognised-top-employer-2022-europe-brazil">Alcon Again Recognised as Top Employer 2022 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-09-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-honored-futureedge-50-award">Alcon Honored with FutureEdge 50 Award | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-recognised-top-employer-2021-europe-brazil">Alcon Recognised as Top Employer 2021 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>3:00 p.m. CDT</h3></div>
          <div class="col-9">
            <p>Clinical subjective performance of two daily disposable soft contact lenses (Friday, May 7, 1:15 – 3:00 p.m. CDT)
  TOTAL30</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-05-01</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/new-alcon-data-contact-lens-dry-eye-and-ocular-health-innovations-be-presented">New Alcon Data on Contact Lens, Dry Eye and Ocular Health Innovations to Be Presented at #ARVO2021 | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>RCOphth</h3></div>
          <div class="col-9">
            <p> Camberley, 20 May 2021 – Alcon, the global leader in eye care dedicated to helping people see brilliantly, is delighted to announce publication of the National Ophthalmology Database (NOD) audit by The Royal College of Ophthalmologists (RCOphth) which collects data on cataract surgery performed in England, Wales and Guernsey with the aim of providing benchmarked reports on performance for surgical centres and individual surgeons to improve patient care.
  This publication was focused on cataract surgery outcomes, notably a study of post-cataract posterior capsule opacification (PCO), analysing over 600,000 operations from 58 centres.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-05-20</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-proud-partner-uk-rcophth-national-ophthalmology-database">Alcon Proud Partner of UK RCOphth National Ophthalmology Database; Data Highlights Benefits of Specific AcrySof Models | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>PCO</h3></div>
          <div class="col-9">
            <p>This publication was focused on cataract surgery outcomes, notably a study of post-cataract posterior capsule opacification (PCO), analysing over 600,000 operations from 58 centres. PCO is the most common post-op complication of cataract surgery and can result in reduced visual acuity, impaired contrast sensitivity and glare disability 1 that sometimes require additional surgical procedures.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-05-20</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-proud-partner-uk-rcophth-national-ophthalmology-database">Alcon Proud Partner of UK RCOphth National Ophthalmology Database; Data Highlights Benefits of Specific AcrySof Models | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Germany</h3></div>
          <div class="col-9">
            <p>In the U.K., Canada, Australia, Singapore and Germany, the device is indicated for primary open-angle glaucoma in conjunction with cataract surgery and as a stand-alone procedure. About Alcon Alcon helps people see brilliantly.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>IQ Vivity TM</h3></div>
          <div class="col-9">
            <p>CEST Moderated by Professor Dr. Gerd Auffarth from Germany, he will be joined by Professor Rudy Nuijts from the Netherlands, Dr. Edoardo Ligabue from Italy, Dr. Ertan Sunay from Turkey and Dr. Norbert Pesztenlehrer from Hungary to discuss innovative approaches to presbyopia correction with AcrySof ® IQ Vivity TM , choosing the right advanced technology IOLs, and using the ARGOS ® Biometer as a smart planning solution. Of the 41 abstracts to be presented, more than half will focus on Alcon’s market-leading intraocular lens technologies, including AcrySof IQ Vivity and PanOptix ® IOLs.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>IQ Vivity</h3></div>
          <div class="col-9">
            <p>Over 40 abstracts highlighting the benefits of Alcon innovation, more than half on Alcon’s leading PC-IOLs, AcrySof IQ Vivity and PanOptix IOLs GENEVA, October 5, 2021 – Alcon, the global leader in eye care dedicated to helping people see brilliantly, will present extensive data during the 2021 Congress of the European Society of Cataract and Refractive Surgery (ESCRS), a hybrid event taking place both virtually and in Amsterdam, Netherlands, from October 8-11. Three symposia and more than 40 abstracts featuring Alcon ophthalmic products and equipment will be presented, reinforcing this industry-leading portfolio.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Swiss</h3></div>
          <div class="col-9">
            <p>Due to the continuing tense situation due to the COVID-19 pandemic, and as a precautionary and prudent measure, Alcon’s Board of Directors decided to hold the AGM in a closed format without the personal attendance of shareholders as permitted by Swiss ordinance and for the safety of Alcon’s shareholders and associates. Alcon asks its shareholders to exercise their rights at the AGM exclusively by sending in voting instructions to the independent representative identified in the voting materials.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-14</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-celebrates-world-sight-day-2021-communities-worldwide-programs-improved-access">Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>SYSTANE</h3></div>
          <div class="col-9">
            <p>The company&rsquor;s robust program featured the introduction of SYSTANE® COMPLETE Preservative-Free (PF) Lubricant Eye Drops and the latest research that supports Alcon&rsquor;s contact lens, dry eye and ocular health portfolios.
  &OpenCurlyDoubleQuote;Alcon is proud to be the title sponsor of SECO as we continue to introduce new products and technologies that help Eye Care Professionals meet their patients&rsquor; evolving needs&rdquor;, said Sean Clark, General Manager, U.S. Vision Care, Alcon. &OpenCurlyDoubleQuote;From DAILIES TOTAL1 for Astigmatism to SYSTANE COMPLETE Preservative-Free, we are excited to introduce these highly anticipated innovations that round out our offerings for people with specific eye care needs and enhance their ability to see even more brilliantly.&rdquor;
 </p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-debuts-dailies-total1-astigmatism-other-eye-care-innovations-title-sponsor-seco">Alcon Debuts DAILIES TOTAL1 for Astigmatism, Other Eye Care Innovations as Title Sponsor of SECO 2022 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-09</th>
                  <td>5 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcons-systane-hydration-preservative-free-lubricant-eye-drop-voted-product-of-year">Alcon’s SYSTANE Hydration Preservative Free Lubricant Eye Drop Voted by Consumers as Eye Care “Product of the Year” | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Schlemm</h3></div>
          <div class="col-9">
            <p>Roughly the size of an eyelash, the Hydrus Microstent is a next-generation MIGS device designed to reduce eye pressure by reestablishing flow through Schlemm's canal, the eye's natural outflow pathway. When placed in the canal during minimally invasive microsurgery, the device restores the flow of fluid in the eye, using a Tri-Modal ® mechanism of action: the Hydrus Microstent dilates and scaffolds</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>PanOptix</h3></div>
          <div class="col-9">
            <p> Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced AcrySof ® IQ PanOptix ® Trifocal Intraocular Lens (IOL) has surpassed more than one million implants worldwide. 2</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-22</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/panoptix-trifocal-iol-surpasses-one-million-implants-worldwide">PanOptix Trifocal IOL Surpasses One Million Implants Worldwide | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-16</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/ora-system-first-and-only-database-real-time-iol-calculations-during-cataract-surgery">ORA System – the First and Only Database for Real-Time IOL Calculations during Cataract Surgery – Reaches 2 Million Cases | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Geneva</h3></div>
          <div class="col-9">
            <p>Investor Relations Daniel Cravens + 41 589 112 110 (Geneva) + 1 817 615 2789 (Fort Worth)</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-21</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-again-recognised-top-employer-2022-europe-brazil">Alcon Again Recognised as Top Employer 2022 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-09-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-honored-futureedge-50-award">Alcon Honored with FutureEdge 50 Award | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-systane-hydration-multi-dose-preservative-free-lubricant-eye-drops-us">Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-host-virtual-capital-markets-day-march-24">Alcon to Host Virtual Capital Markets Day on March 24 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-recognised-top-employer-2021-europe-brazil">Alcon Recognised as Top Employer 2021 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Board</h3></div>
          <div class="col-9">
            <p>{ vertical-align: top } Alcon Board of Directors proposes to elect Raquel C. Bono, M.D. as a new Board member Shareholders asked to exercise voting rights exclusively by sending voting instructions to the independent representative due to closed format Proposed dividend of CHF 0.20 cash per share with expected record date of May 2 and payout date on May 5 GENEVA--(BUSINESS</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>NGENUITY</h3></div>
          <div class="col-9">
            <p>CEST Moderated by Dr. Saleh Al Messabi, he will be joined by Dr. Khalid Al Sabti from Kuwait, Dr. Kjell Gunnar Gundersen from Norway and Professor Robert Rejdak from Poland to introduce NGENUITY ® 3D Visualization System enhancements for both posterior and anterior segments, and present the benefits in terms of safety and efficacy of the ACTIVE SENTRY ® Handpiece and INTREPID ® Hybrid Tip to anterior segment surgeons and fellows through a series of surgical cases. 1-6 Advancing Cataract Refractive Surgery and Presbyopia Correction – Better Outcomes for More Patients</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>lehfilcon</h3></div>
          <div class="col-9">
            <p>HEVL and UV transmittance properties of lehfilcon A contact lenses. Presented by Dr. Brian Loudermilk.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-11</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-debuts-dailies-total1-astigmatism-other-eye-care-innovations-title-sponsor-seco">Alcon Debuts DAILIES TOTAL1 for Astigmatism, Other Eye Care Innovations as Title Sponsor of SECO 2022 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Clareon</h3></div>
          <div class="col-9">
            <p>{ text-decoration: underline } Clareon family of intraocular lenses (IOLs) delivers excellent vision, exceptional clarity and predictable refractive outcomes in a glistening-free § IOL material 1-3 Long-lasting clarity of the Clareon IOL and extensive real-world experience with excellent outcomes demonstrated in 30 peer-reviewed studies 4-6 Global rollout of Clareon portfolio has started; U.S. to launch Clareon Monofocal, Clareon PanOptix and Clareon Vivity IOLs in March with additional countries planned throughout 2022 GENEVA--(BUSINESS</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Eye Care Professionals</h3></div>
          <div class="col-9">
            <p>Our more than 24,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com .</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-22</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/panoptix-trifocal-iol-surpasses-one-million-implants-worldwide">PanOptix Trifocal IOL Surpasses One Million Implants Worldwide | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-debuts-dailies-total1-astigmatism-other-eye-care-innovations-title-sponsor-seco">Alcon Debuts DAILIES TOTAL1 for Astigmatism, Other Eye Care Innovations as Title Sponsor of SECO 2022 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/new-alcon-data-contact-lens-dry-eye-and-ocular-health-innovations-be-presented">New Alcon Data on Contact Lens, Dry Eye and Ocular Health Innovations to Be Presented at #ARVO2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>World Sight Day</h3></div>
          <div class="col-9">
            <p> GENEVA, October 14, 2021 – Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today celebrates World Sight Day 2021 by taking action in communities across the globe to raise awareness of blindness and vision impairment as global public health issues. Celebrated annually in October, World Sight Day is coordinated by the International Agency for the Prevention of Blindness (IAPB).</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-10-14</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-celebrates-world-sight-day-2021-communities-worldwide-programs-improved-access">Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Systane iLux</h3></div>
          <div class="col-9">
            <p>“We’re thrilled to share new updates on some of our most important innovations including long-term efficacy of Systane iLux, head-to-head performance results for PRECISION1– the fastest-growing daily disposable lens among optometrists in the U.S. * – and promising data on our forthcoming TOTAL30 monthly replacement contact lens,” said Sean Clark, General Manager, U.S. Vision Care at Alcon.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-05-01</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/new-alcon-data-contact-lens-dry-eye-and-ocular-health-innovations-be-presented">New Alcon Data on Contact Lens, Dry Eye and Ocular Health Innovations to Be Presented at #ARVO2021 | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Alcon&rsquor;s</h3></div>
          <div class="col-9">
            <p>The company&rsquor;s robust program featured the introduction of SYSTANE® COMPLETE Preservative-Free (PF) Lubricant Eye Drops and the latest research that supports Alcon&rsquor;s contact lens, dry eye and ocular health portfolios.
  &OpenCurlyDoubleQuote;Alcon is proud to be the title sponsor of SECO as we continue to introduce new products and technologies that help Eye Care Professionals meet their patients&rsquor; evolving needs&rdquor;, said Sean Clark, General Manager, U.S. Vision Care, Alcon. &OpenCurlyDoubleQuote;From DAILIES TOTAL1 for Astigmatism to SYSTANE COMPLETE Preservative-Free, we are excited to introduce these highly anticipated innovations that round out our offerings for people with specific eye care needs and enhance their ability to see even more brilliantly.&rdquor;
 </p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-11</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-debuts-dailies-total1-astigmatism-other-eye-care-innovations-title-sponsor-seco">Alcon Debuts DAILIES TOTAL1 for Astigmatism, Other Eye Care Innovations as Title Sponsor of SECO 2022 | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>ForeSight</h3></div>
          <div class="col-9">
            <p>{ text-decoration: underline } Award recognizes Alcon’s ForeSight enterprise data and analytics platform FORT WORTH, September 27, 2021 – Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has been recognized as a recipient of the FutureEdge 50 Award from International Data Group (IDG). This prestigious award is bestowed upon organizations for pushing the edge with innovative technologies to advance their business for the future.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-09-27</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-honored-futureedge-50-award">Alcon Honored with FutureEdge 50 Award | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Clareon Monofocal</h3></div>
          <div class="col-9">
            <p>{ text-decoration: underline } Clareon family of intraocular lenses (IOLs) delivers excellent vision, exceptional clarity and predictable refractive outcomes in a glistening-free § IOL material 1-3 Long-lasting clarity of the Clareon IOL and extensive real-world experience with excellent outcomes demonstrated in 30 peer-reviewed studies 4-6 Global rollout of Clareon portfolio has started; U.S. to launch Clareon Monofocal, Clareon PanOptix and Clareon Vivity IOLs in March with additional countries planned throughout 2022 GENEVA--(BUSINESS</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>SYSTANE Hydration PF</h3></div>
          <div class="col-9">
            <p>“Since launch, SYSTANE Hydration PF (Preservative Free) has provided a much-needed option for consumers needing long-lasting moisture to soothe sensitive, dry eyes,” said Justin Hart, Senior Brand Manager of SYSTANE and GenTeal, Alcon. “Being recognized as Product of the Year is a testament to the important place this product has in our OTC dry eye drop portfolio and shows that consumers trust SYSTANE Hydration PF to provide long-lasting relief for their dry eyes.”
 </p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-03-09</th>
                  <td>4 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcons-systane-hydration-preservative-free-lubricant-eye-drop-voted-product-of-year">Alcon’s SYSTANE Hydration Preservative Free Lubricant Eye Drop Voted by Consumers as Eye Care “Product of the Year” | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>the United States Private Securities Litigation Reform Act</h3></div>
          <div class="col-9">
            <p>This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “commitment,” “</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-debuts-dailies-total1-astigmatism-other-eye-care-innovations-title-sponsor-seco">Alcon Debuts DAILIES TOTAL1 for Astigmatism, Other Eye Care Innovations as Title Sponsor of SECO 2022 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-academy21-program-showcase-total30-other-innovations-meet-critical-patient-and">Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-14</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-celebrates-world-sight-day-2021-communities-worldwide-programs-improved-access">Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>the United States</h3></div>
          <div class="col-9">
            <p>Eye care markets in the fourth quarter reflected the recovery in the United States and the continuing recovery internationally from the COVID-19 pandemic. Worldwide sales for full year 2021 were $8.2 billion, an increase of 22% on a reported basis and 20% on a constant currency basis, compared to 2020.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-retina-fellows-institute-brings-together-world-class-ophthalmology-leaders">Alcon Retina Fellows Institute Brings Together World-Class Ophthalmology Leaders to Train Next Generation of Retina Surgeons | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Media Relations</h3></div>
          <div class="col-9">
            <p>[email protected] Media Relations Steven Smith + 41 589 112 111 (Geneva)</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-systane-hydration-multi-dose-preservative-free-lubricant-eye-drops-us">Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-host-virtual-capital-markets-day-march-24">Alcon to Host Virtual Capital Markets Day on March 24 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Alcon Alcon</h3></div>
          <div class="col-9">
            <p>About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-09-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-honored-futureedge-50-award">Alcon Honored with FutureEdge 50 Award | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-host-virtual-capital-markets-day-march-24">Alcon to Host Virtual Capital Markets Day on March 24 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Alcon Data on File</h3></div>
          <div class="col-9">
            <p>Alcon Data on File, 2021. CLAREON MONARCH IV IOL Delivery System – Proposed Instructions for Use – Final Modi Et al.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>the US Private Securities Litigation Reform Act</h3></div>
          <div class="col-9">
            <p>This press release contains, and our officers and representatives may from time to time make, certain “forward-looking statements” within the meaning of the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipate,” “intend,” “commitment,” “look forward,” “maintain,” “plan,” “goal,” “seek,” “target,” “assume,” “believe,”</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>the US Foreign Corrupt Practices Act</h3></div>
          <div class="col-9">
            <p>Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict such as: cybersecurity breaches or other disruptions of our information technology systems; compliance with data privacy, identity protection and information security laws; our ability to comply with the US Foreign Corrupt Practices Act of 1977 and other applicable anti-corruption laws, particularly given that we have entered into a three-year Deferred Prosecution Agreement with the U.S. Department of Justice; our success in completing and integrating strategic acquisitions; the impact of a disruption in our global supply chain or important facilities; the effect of the COVID-19 pandemic as well as other viral or disease outbreaks; global and regional economic, financial, legal, tax, political and social change; the commercial success of our products and our ability to maintain and strengthen our position in our markets; the success of our research and development efforts, including our ability to innovate to compete effectively; pricing pressure from changes in third party payor coverage and reimbursement methodologies; ongoing industry consolidation; our ability to properly educate and train healthcare providers on our products; the impact of unauthorized importation of our products from countries with lower prices to countries with higher prices; our reliance on outsourcing key business functions; changes in inventory levels or buying patterns of our customers; our ability to attract and retain qualified personnel; our ability to service our debt obligations; the need for additional financing through the issuance of debt or equity; our ability to protect our intellectual property; the effects of litigation, including product liability lawsuits and governmental investigations; our ability to comply with all laws to which we may be subject; effect of product recalls or voluntary market withdrawals; the implementation of our enterprise resource planning system; the accuracy of our accounting estimates and assumptions, including pension and other post-employment benefit plan obligations and the carrying value of intangible assets; the ability to obtain regulatory clearance and approval of our products as well as compliance with any post-approval obligations, including quality control of our manufacturing; legislative, tax and regulatory reform; the ability of Alcon Pharmaceuticals Ltd. to comply with its investment tax incentive agreement with the Swiss State Secretariat for Economic Affairs in Switzerland and the Canton of Fribourg, Switzerland; our ability to manage environmental, social and governance matters to the satisfaction of our many stakeholders, some of which may have competing interests; the impact of being listed on two stock exchanges; the ability to declare and pay dividends; the different rights afforded to our shareholders as a Swiss corporation compared to a U.S. corporation; and the effect of maintaining or losing our foreign private issuer status under U.S. securities laws. Additional factors are discussed in our filings with the United States Securities and Exchange Commission, including our Form 20-F.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Alcon Pharmaceuticals Ltd.</h3></div>
          <div class="col-9">
            <p>Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict such as: cybersecurity breaches or other disruptions of our information technology systems; compliance with data privacy, identity protection and information security laws; our ability to comply with the US Foreign Corrupt Practices Act of 1977 and other applicable anti-corruption laws, particularly given that we have entered into a three-year Deferred Prosecution Agreement with the U.S. Department of Justice; our success in completing and integrating strategic acquisitions; the impact of a disruption in our global supply chain or important facilities; the effect of the COVID-19 pandemic as well as other viral or disease outbreaks; global and regional economic, financial, legal, tax, political and social change; the commercial success of our products and our ability to maintain and strengthen our position in our markets; the success of our research and development efforts, including our ability to innovate to compete effectively; pricing pressure from changes in third party payor coverage and reimbursement methodologies; ongoing industry consolidation; our ability to properly educate and train healthcare providers on our products; the impact of unauthorized importation of our products from countries with lower prices to countries with higher prices; our reliance on outsourcing key business functions; changes in inventory levels or buying patterns of our customers; our ability to attract and retain qualified personnel; our ability to service our debt obligations; the need for additional financing through the issuance of debt or equity; our ability to protect our intellectual property; the effects of litigation, including product liability lawsuits and governmental investigations; our ability to comply with all laws to which we may be subject; effect of product recalls or voluntary market withdrawals; the implementation of our enterprise resource planning system; the accuracy of our accounting estimates and assumptions, including pension and other post-employment benefit plan obligations and the carrying value of intangible assets; the ability to obtain regulatory clearance and approval of our products as well as compliance with any post-approval obligations, including quality control of our manufacturing; legislative, tax and regulatory reform; the ability of Alcon Pharmaceuticals Ltd. to comply with its investment tax incentive agreement with the Swiss State Secretariat for Economic Affairs in Switzerland and the Canton of Fribourg, Switzerland; our ability to manage environmental, social and governance matters to the satisfaction of our many stakeholders, some of which may have competing interests; the impact of being listed on two stock exchanges; the ability to declare and pay dividends; the different rights afforded to our shareholders as a Swiss corporation compared to a U.S. corporation; and the effect of maintaining or losing our foreign private issuer status under U.S. securities laws. Additional factors are discussed in our filings with the United States Securities and Exchange Commission, including our Form 20-F.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>the Swiss State Secretariat for Economic Affairs</h3></div>
          <div class="col-9">
            <p>Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict such as: cybersecurity breaches or other disruptions of our information technology systems; compliance with data privacy, identity protection and information security laws; our ability to comply with the US Foreign Corrupt Practices Act of 1977 and other applicable anti-corruption laws, particularly given that we have entered into a three-year Deferred Prosecution Agreement with the U.S. Department of Justice; our success in completing and integrating strategic acquisitions; the impact of a disruption in our global supply chain or important facilities; the effect of the COVID-19 pandemic as well as other viral or disease outbreaks; global and regional economic, financial, legal, tax, political and social change; the commercial success of our products and our ability to maintain and strengthen our position in our markets; the success of our research and development efforts, including our ability to innovate to compete effectively; pricing pressure from changes in third party payor coverage and reimbursement methodologies; ongoing industry consolidation; our ability to properly educate and train healthcare providers on our products; the impact of unauthorized importation of our products from countries with lower prices to countries with higher prices; our reliance on outsourcing key business functions; changes in inventory levels or buying patterns of our customers; our ability to attract and retain qualified personnel; our ability to service our debt obligations; the need for additional financing through the issuance of debt or equity; our ability to protect our intellectual property; the effects of litigation, including product liability lawsuits and governmental investigations; our ability to comply with all laws to which we may be subject; effect of product recalls or voluntary market withdrawals; the implementation of our enterprise resource planning system; the accuracy of our accounting estimates and assumptions, including pension and other post-employment benefit plan obligations and the carrying value of intangible assets; the ability to obtain regulatory clearance and approval of our products as well as compliance with any post-approval obligations, including quality control of our manufacturing; legislative, tax and regulatory reform; the ability of Alcon Pharmaceuticals Ltd. to comply with its investment tax incentive agreement with the Swiss State Secretariat for Economic Affairs in Switzerland and the Canton of Fribourg, Switzerland; our ability to manage environmental, social and governance matters to the satisfaction of our many stakeholders, some of which may have competing interests; the impact of being listed on two stock exchanges; the ability to declare and pay dividends; the different rights afforded to our shareholders as a Swiss corporation compared to a U.S. corporation; and the effect of maintaining or losing our foreign private issuer status under U.S. securities laws. Additional factors are discussed in our filings with the United States Securities and Exchange Commission, including our Form 20-F.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Canton</h3></div>
          <div class="col-9">
            <p>Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict such as: cybersecurity breaches or other disruptions of our information technology systems; compliance with data privacy, identity protection and information security laws; our ability to comply with the US Foreign Corrupt Practices Act of 1977 and other applicable anti-corruption laws, particularly given that we have entered into a three-year Deferred Prosecution Agreement with the U.S. Department of Justice; our success in completing and integrating strategic acquisitions; the impact of a disruption in our global supply chain or important facilities; the effect of the COVID-19 pandemic as well as other viral or disease outbreaks; global and regional economic, financial, legal, tax, political and social change; the commercial success of our products and our ability to maintain and strengthen our position in our markets; the success of our research and development efforts, including our ability to innovate to compete effectively; pricing pressure from changes in third party payor coverage and reimbursement methodologies; ongoing industry consolidation; our ability to properly educate and train healthcare providers on our products; the impact of unauthorized importation of our products from countries with lower prices to countries with higher prices; our reliance on outsourcing key business functions; changes in inventory levels or buying patterns of our customers; our ability to attract and retain qualified personnel; our ability to service our debt obligations; the need for additional financing through the issuance of debt or equity; our ability to protect our intellectual property; the effects of litigation, including product liability lawsuits and governmental investigations; our ability to comply with all laws to which we may be subject; effect of product recalls or voluntary market withdrawals; the implementation of our enterprise resource planning system; the accuracy of our accounting estimates and assumptions, including pension and other post-employment benefit plan obligations and the carrying value of intangible assets; the ability to obtain regulatory clearance and approval of our products as well as compliance with any post-approval obligations, including quality control of our manufacturing; legislative, tax and regulatory reform; the ability of Alcon Pharmaceuticals Ltd. to comply with its investment tax incentive agreement with the Swiss State Secretariat for Economic Affairs in Switzerland and the Canton of Fribourg, Switzerland; our ability to manage environmental, social and governance matters to the satisfaction of our many stakeholders, some of which may have competing interests; the impact of being listed on two stock exchanges; the ability to declare and pay dividends; the different rights afforded to our shareholders as a Swiss corporation compared to a U.S. corporation; and the effect of maintaining or losing our foreign private issuer status under U.S. securities laws. Additional factors are discussed in our filings with the United States Securities and Exchange Commission, including our Form 20-F.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Fribourg</h3></div>
          <div class="col-9">
            <p>Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict such as: cybersecurity breaches or other disruptions of our information technology systems; compliance with data privacy, identity protection and information security laws; our ability to comply with the US Foreign Corrupt Practices Act of 1977 and other applicable anti-corruption laws, particularly given that we have entered into a three-year Deferred Prosecution Agreement with the U.S. Department of Justice; our success in completing and integrating strategic acquisitions; the impact of a disruption in our global supply chain or important facilities; the effect of the COVID-19 pandemic as well as other viral or disease outbreaks; global and regional economic, financial, legal, tax, political and social change; the commercial success of our products and our ability to maintain and strengthen our position in our markets; the success of our research and development efforts, including our ability to innovate to compete effectively; pricing pressure from changes in third party payor coverage and reimbursement methodologies; ongoing industry consolidation; our ability to properly educate and train healthcare providers on our products; the impact of unauthorized importation of our products from countries with lower prices to countries with higher prices; our reliance on outsourcing key business functions; changes in inventory levels or buying patterns of our customers; our ability to attract and retain qualified personnel; our ability to service our debt obligations; the need for additional financing through the issuance of debt or equity; our ability to protect our intellectual property; the effects of litigation, including product liability lawsuits and governmental investigations; our ability to comply with all laws to which we may be subject; effect of product recalls or voluntary market withdrawals; the implementation of our enterprise resource planning system; the accuracy of our accounting estimates and assumptions, including pension and other post-employment benefit plan obligations and the carrying value of intangible assets; the ability to obtain regulatory clearance and approval of our products as well as compliance with any post-approval obligations, including quality control of our manufacturing; legislative, tax and regulatory reform; the ability of Alcon Pharmaceuticals Ltd. to comply with its investment tax incentive agreement with the Swiss State Secretariat for Economic Affairs in Switzerland and the Canton of Fribourg, Switzerland; our ability to manage environmental, social and governance matters to the satisfaction of our many stakeholders, some of which may have competing interests; the impact of being listed on two stock exchanges; the ability to declare and pay dividends; the different rights afforded to our shareholders as a Swiss corporation compared to a U.S. corporation; and the effect of maintaining or losing our foreign private issuer status under U.S. securities laws. Additional factors are discussed in our filings with the United States Securities and Exchange Commission, including our Form 20-F.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>the United States Securities and Exchange Commission</h3></div>
          <div class="col-9">
            <p>Some of these factors are discussed in our filings with the United States Securities and Exchange Commission, including our Form 20-F. Should one or more of these uncertainties or risks materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-debuts-dailies-total1-astigmatism-other-eye-care-innovations-title-sponsor-seco">Alcon Debuts DAILIES TOTAL1 for Astigmatism, Other Eye Care Innovations as Title Sponsor of SECO 2022 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-academy21-program-showcase-total30-other-innovations-meet-critical-patient-and">Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-14</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-celebrates-world-sight-day-2021-communities-worldwide-programs-improved-access">Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Form 20-F.</h3></div>
          <div class="col-9">
            <p>Some of these factors are discussed in our filings with the United States Securities and Exchange Commission, including our Form 20-F. Should one or more of these uncertainties or risks materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-debuts-dailies-total1-astigmatism-other-eye-care-innovations-title-sponsor-seco">Alcon Debuts DAILIES TOTAL1 for Astigmatism, Other Eye Care Innovations as Title Sponsor of SECO 2022 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-academy21-program-showcase-total30-other-innovations-meet-critical-patient-and">Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-14</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-celebrates-world-sight-day-2021-communities-worldwide-programs-improved-access">Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>M.D.</h3></div>
          <div class="col-9">
            <p>{ vertical-align: top } Alcon Board of Directors proposes to elect Raquel C. Bono, M.D. as a new Board member Shareholders asked to exercise voting rights exclusively by sending voting instructions to the independent representative due to closed format Proposed dividend of CHF 0.20 cash per share with expected record date of May 2 and payout date on May 5 GENEVA--(BUSINESS</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-systane-hydration-multi-dose-preservative-free-lubricant-eye-drops-us">Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Canada</h3></div>
          <div class="col-9">
            <p>In the U.K., Canada, Australia, Singapore and Germany, the device is indicated for primary open-angle glaucoma in conjunction with cataract surgery and as a stand-alone procedure. About Alcon Alcon helps people see brilliantly.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>the US Department of Justice</h3></div>
          <div class="col-9">
            <p>Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict such as: the effect of the COVID-19 pandemic as well as other viral or disease outbreaks and the availability and the public’s acceptance of vaccines; the commercial success of its products and its ability to maintain and strengthen its position in its markets; the success of its research and development efforts, including its ability to innovate to compete effectively; its success in completing and integrating strategic acquisitions; the possibility that various closing conditions for the transaction may not be satisfied or waived, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the transaction; transaction costs; pricing pressure from changes in third party payor coverage and reimbursement methodologies; global and regional economic, financial, legal, tax, political, and social change; data breaches or other disruptions of its information technology systems; ongoing industry consolidation; its ability to properly educate and train healthcare providers on its products; changes in inventory levels or buying patterns of its customers; the impact of a disruption in its global supply chain or important facilities; ability to service its debt obligations; its ability to comply with the US Foreign Corrupt Practices Act of 1977 and other applicable anti-corruption laws, particularly given that it has entered into a three-year Deferred Prosecution Agreement with the US Department of Justice; uncertainty and impact relating to the potential phasing out of LIBOR and transition to alternative reference rates; the need for additional financing through the issuance of debt or equity; its reliance on outsourcing key business functions; its ability to protect its intellectual property; the impact of unauthorized importation of its products from countries with lower prices to countries with higher prices; uncertainties regarding the success of Alcon's separation and Spin-off from Novartis and the subsequent transformation program, including the expected separation and transformation costs, as well as any potential savings, incurred or realized by Alcon; the effects of litigation, including product liability lawsuits and government investigations; its ability to comply with all laws to which it may be subject; effect of product recalls or voluntary market withdrawals; the implementation of its enterprise resource planning system; its ability to attract and retain qualified personnel; the accuracy of its accounting estimates and assumptions, including pension plan obligations and the carrying value of intangible assets; the ability to obtain regulatory clearance and approval of its products as well as compliance with any post-approval obligations, including quality control of its manufacturing; legislative and regulatory reform; the ability of Alcon Pharmaceuticals Ltd. to comply with its investment tax incentive agreement with the Swiss State Secretariat for Economic Affairs in Switzerland and the Canton of Fribourg, Switzerland; its ability to manage environmental, social and governance matters to the satisfaction of its many stakeholders, some of which may have competing interests; its ability to operate as a stand-alone company; whether the transitional services Novartis has agreed to provide Alcon are sufficient; the impact of the spin-off from Novartis on Alcon's shareholder base; the impact of being listed on two stock exchanges; the ability to declare and pay dividends; the different rights afforded to its shareholders as a Swiss corporation compared to a US corporation; and the effect of maintaining or losing its foreign private issuer status under US securities laws. Additional factors are discussed in Alcon’s filings with the United States Securities and Exchange Commission, including its Form 20-F.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>more than 260 million</h3></div>
          <div class="col-9">
            <p>Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 24,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-09-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-honored-futureedge-50-award">Alcon Honored with FutureEdge 50 Award | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-systane-hydration-multi-dose-preservative-free-lubricant-eye-drops-us">Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-host-virtual-capital-markets-day-march-24">Alcon to Host Virtual Capital Markets Day on March 24 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Alcon Inc. Investors</h3></div>
          <div class="col-9">
            <p>Alcon Inc. Investors</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-systane-hydration-multi-dose-preservative-free-lubricant-eye-drops-us">Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-host-virtual-capital-markets-day-march-24">Alcon to Host Virtual Capital Markets Day on March 24 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Pataday</h3></div>
          <div class="col-9">
            <p>strong demand for Precision1, Systane and Pataday Vision Care net sales of $0.9 billion, which include contact lenses and ocular health, increased 49%, or 44% on a constant currency basis, compared to the second quarter of 2020, also with double-digit increases across both categories. Contact lens growth reflected improvements in all product categories and continued momentum from the launch of Precision1 and Precision1 for Astigmatism.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Annual General Meeting</h3></div>
          <div class="col-9">
            <p>WIRE)--
Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on April 27, 2022. Due to the continuing tense situation due to the COVID-19 pandemic, and as a precautionary and prudent measure, Alcon’s Board of Directors decided to hold the AGM in a closed format without the personal attendance of shareholders as permitted by Swiss ordinance and for the safety of Alcon’s shareholders and associates.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Water Gradient</h3></div>
          <div class="col-9">
            <p>{ text-decoration: underline } The first and only Water Gradient contact lens for patients with astigmatism, available in the U.S. beginning in March DAILIES TOTAL1 for Astigmatism joins DAILIES TOTAL1 sphere and multifocal for a full portfolio designed for the premium, daily disposable lens market Toric is the fastest-growing contact lens market segment GENEVA--(BUSINESS WIRE)--
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the launch of DAILIES TOTAL1 ® for Astigmatism, the first and only Water Gradient contact lens for patients with astigmatism. The lenses will be available in the U.S. beginning in March.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-dozen-scientific-presentations-unique-water-surface-contact-lens">Alcon to Showcase a Dozen Scientific Presentations on Unique Water Surface Contact Lens Technologies at #Academy21 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-01</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-academy21-program-showcase-total30-other-innovations-meet-critical-patient-and">Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-09-03</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/optometry-reference-guide-creates-new-category-alcons-permanent-water-surface-lenses">Optometry Reference Guide Creates New Category for Alcon’s Permanent Water Surface Lenses | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>24 hours</h3></div>
          <div class="col-9">
            <p>More than 92% of cataract surgeries are considered successful, and patients typically can return to their normal routines within 24 hours. 21</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>iLux</h3></div>
          <div class="col-9">
            <p>New Clinical Findings Affirm Efficacy of Products in Alcon’s Dry Eye and Ocular Health Portfolio
 Alcon’s dry eye and ocular health portfolio features over-the-counter solutions and in-office devices, such as Systane ® iLux ® , Pataday ® Once Daily Relief Extra Strength, and a variety of other brands, which support ocular surface health, dry eye, eye allergy itch symptom relief and more.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-11-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-academy21-program-showcase-total30-other-innovations-meet-critical-patient-and">Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-01</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/new-alcon-data-contact-lens-dry-eye-and-ocular-health-innovations-be-presented">New Alcon Data on Contact Lens, Dry Eye and Ocular Health Innovations to Be Presented at #ARVO2021 | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>CIO</h3></div>
          <div class="col-9">
            <p>The FutureEdge 50 Award comes on the heels of an array of acknowledgments Alcon received this year, including the CIO of the Year ORBIE Award; Best Place to Work 2021 certification: Alcon U.S. and Alcon Malaysia; Top Employer 2021 certification: Europe; and, Top Employer 2021 certification: Alcon Brazil, Alcon France, Alcon Poland, Alcon Russia, Alcon Spain and Alcon Switzerland, among others.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-09-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-honored-futureedge-50-award">Alcon Honored with FutureEdge 50 Award | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-01</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcons-sue-jean-lin-wins-2021-dallas-cio-year">Alcon’s Sue-Jean Lin Wins 2021 Dallas CIO of the Year | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Brazil</h3></div>
          <div class="col-9">
            <p> Geneva, January 21, 2022 – Alcon, the global leader in eye care dedicated to helping people see brilliantly, has again been recognised as a Top Employer 2022 in six markets – Brazil, France, Poland, Russia, Spain and Switzerland. Each year, Top Employers Institute certifies organisations who are focused on putting their people first through their exceptional Human Resources (HR) policies.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-21</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-again-recognised-top-employer-2022-europe-brazil">Alcon Again Recognised as Top Employer 2022 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-27</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-recognised-top-employer-2021-europe-brazil">Alcon Recognised as Top Employer 2021 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Employers Institute</h3></div>
          <div class="col-9">
            <p>Each year, Top Employers Institute certifies organisations who are focused on putting their people first through their exceptional Human Resources (HR) policies. The Top Employers Institute programme certifies organisations based on the participation and results of their HR Best Practices Survey.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-21</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-again-recognised-top-employer-2022-europe-brazil">Alcon Again Recognised as Top Employer 2022 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-recognised-top-employer-2021-europe-brazil">Alcon Recognised as Top Employer 2021 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Singapore</h3></div>
          <div class="col-9">
            <p>In the U.K., Canada, Australia, Singapore and Germany, the device is indicated for primary open-angle glaucoma in conjunction with cataract surgery and as a stand-alone procedure. About Alcon Alcon helps people see brilliantly.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Lehfilcon</h3></div>
          <div class="col-9">
            <p>Antimicrobial Efficacy of Contact Lens Care Products in the Presence of Lehfilcon A Contact Lenses. Presented by Dr. Manal M. Gabriel, 10:15 – 10:30 a.m. ET</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-11-04</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-dozen-scientific-presentations-unique-water-surface-contact-lens">Alcon to Showcase a Dozen Scientific Presentations on Unique Water Surface Contact Lens Technologies at #Academy21 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-01</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-academy21-program-showcase-total30-other-innovations-meet-critical-patient-and">Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Spain</h3></div>
          <div class="col-9">
            <p> Geneva, January 21, 2022 – Alcon, the global leader in eye care dedicated to helping people see brilliantly, has again been recognised as a Top Employer 2022 in six markets – Brazil, France, Poland, Russia, Spain and Switzerland. Each year, Top Employers Institute certifies organisations who are focused on putting their people first through their exceptional Human Resources (HR) policies.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-21</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-again-recognised-top-employer-2022-europe-brazil">Alcon Again Recognised as Top Employer 2022 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-09-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-honored-futureedge-50-award">Alcon Honored with FutureEdge 50 Award | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-recognised-top-employer-2021-europe-brazil">Alcon Recognised as Top Employer 2021 in Europe & Brazil | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Board of Directors</h3></div>
          <div class="col-9">
            <p>{ vertical-align: top } Alcon Board of Directors proposes to elect Raquel C. Bono, M.D. as a new Board member Shareholders asked to exercise voting rights exclusively by sending voting instructions to the independent representative due to closed format Proposed dividend of CHF 0.20 cash per share with expected record date of May 2 and payout date on May 5 GENEVA--(BUSINESS</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>FDA</h3></div>
          <div class="col-9">
            <p>Approved by the FDA in August 2018 for use in conjunction with cataract surgery, the Hydrus Microstent is one of the most rigorously researched and thoroughly studied MIGS devices. References Ahmed, I.K. (2021, Mar. 4-7).</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>2 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Facebook</h3></div>
          <div class="col-9">
            <p>Connect with us on Facebook LinkedIn View source version on businesswire.com :</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-2022-annual-general-meeting">Alcon Publishes Agenda for 2022 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-22</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/panoptix-trifocal-iol-surpasses-one-million-implants-worldwide">PanOptix Trifocal IOL Surpasses One Million Implants Worldwide | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-02-15</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2021-results">Alcon Reports Fourth Quarter and Full Year 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-dailies-total1-contact-lenses-us-patients-astigmatism">Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2022-01-10</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-completes-acquisition-ivantis-inc-bringing-hydrus-microstent-its-global">Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-09</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-third-quarter-2021-results">Alcon Reports Third Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-11-08</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-09-27</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-honored-futureedge-50-award">Alcon Honored with FutureEdge 50 Award | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-17</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-second-quarter-2021-results">Alcon Reports Second Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-08-11</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launch-total30-first-and-only-monthly-replacement-water-gradient-contact-lens">Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-07-22</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reinforces-strength-industry-leading-ophthalmology-portfolio-largest-surgical">Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-showcase-vision-care-innovation-including-clinical-data-its-forthcoming">Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-06-01</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-retina-fellows-institute-brings-together-world-class-ophthalmology-leaders">Alcon Retina Fellows Institute Brings Together World-Class Ophthalmology Leaders to Train Next Generation of Retina Surgeons | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-05-04</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-first-quarter-2021-results">Alcon Reports First Quarter 2021 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-shareholders-approve-all-binding-resolutions-2021-annual-general-meeting">Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-04-28</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-acquire-us-commercialization-rights-ophthalmic-eye-drop-simbrinza">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-24</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-publishes-agenda-annual-general-meeting">Alcon Publishes Agenda for Annual General Meeting | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-03-12</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-host-virtual-capital-markets-day-march-24">Alcon to Host Virtual Capital Markets Day on March 24 | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-23</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-reports-fourth-quarter-and-full-year-2020-results">Alcon Reports Fourth Quarter and Full Year 2020 Results | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-20</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-launches-precision1-astigmatism-contact-lenses-us">Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S. | Alcon.com</a></td>
                </tr>
    
                <tr>
                  <th scope="row">2021-01-07</th>
                  <td>1 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-acrysof-iq-vivity-first-and-only-non-diffractive-extended">Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>ECA</h3></div>
          <div class="col-9">
            <p>WIRE)--
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced changes to its Executive Committee of Alcon (ECA). Changes take effect September 1, 2021.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-06-28</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-executive-committee-changes">Alcon Announces Executive Committee Changes | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>ESCRS</h3></div>
          <div class="col-9">
            <p>Over 40 abstracts highlighting the benefits of Alcon innovation, more than half on Alcon’s leading PC-IOLs, AcrySof IQ Vivity and PanOptix IOLs GENEVA, October 5, 2021 – Alcon, the global leader in eye care dedicated to helping people see brilliantly, will present extensive data during the 2021 Congress of the European Society of Cataract and Refractive Surgery (ESCRS), a hybrid event taking place both virtually and in Amsterdam, Netherlands, from October 8-11. Three symposia and more than 40 abstracts featuring Alcon ophthalmic products and equipment will be presented, reinforcing this industry-leading portfolio.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-10-05</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-presents-complete-scientific-program-escrs-2021">Alcon Presents Complete Scientific Program at ESCRS 2021 | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Systane Complete Preservative-Free</h3></div>
          <div class="col-9">
            <p>With the launch of Systane Complete Preservative-Free , Alcon now offers a full portfolio of preservative-free artificial tears in multi-dose bottles. This expands Alcon’s footprint in the large and fast-growing artificial tears category, which is approximately $1 billion in annual sales.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-01-12</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-launch-systane-complete-preservative-free-lubricant-eye-drops-europe">Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>England</h3></div>
          <div class="col-9">
            <p> Camberley, 20 May 2021 – Alcon, the global leader in eye care dedicated to helping people see brilliantly, is delighted to announce publication of the National Ophthalmology Database (NOD) audit by The Royal College of Ophthalmologists (RCOphth) which collects data on cataract surgery performed in England, Wales and Guernsey with the aim of providing benchmarked reports on performance for surgical centres and individual surgeons to improve patient care.
  This publication was focused on cataract surgery outcomes, notably a study of post-cataract posterior capsule opacification (PCO), analysing over 600,000 operations from 58 centres.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-05-20</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-proud-partner-uk-rcophth-national-ophthalmology-database">Alcon Proud Partner of UK RCOphth National Ophthalmology Database; Data Highlights Benefits of Specific AcrySof Models | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Wales</h3></div>
          <div class="col-9">
            <p> Camberley, 20 May 2021 – Alcon, the global leader in eye care dedicated to helping people see brilliantly, is delighted to announce publication of the National Ophthalmology Database (NOD) audit by The Royal College of Ophthalmologists (RCOphth) which collects data on cataract surgery performed in England, Wales and Guernsey with the aim of providing benchmarked reports on performance for surgical centres and individual surgeons to improve patient care.
  This publication was focused on cataract surgery outcomes, notably a study of post-cataract posterior capsule opacification (PCO), analysing over 600,000 operations from 58 centres.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-05-20</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-proud-partner-uk-rcophth-national-ophthalmology-database">Alcon Proud Partner of UK RCOphth National Ophthalmology Database; Data Highlights Benefits of Specific AcrySof Models | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Guernsey</h3></div>
          <div class="col-9">
            <p> Camberley, 20 May 2021 – Alcon, the global leader in eye care dedicated to helping people see brilliantly, is delighted to announce publication of the National Ophthalmology Database (NOD) audit by The Royal College of Ophthalmologists (RCOphth) which collects data on cataract surgery performed in England, Wales and Guernsey with the aim of providing benchmarked reports on performance for surgical centres and individual surgeons to improve patient care.
  This publication was focused on cataract surgery outcomes, notably a study of post-cataract posterior capsule opacification (PCO), analysing over 600,000 operations from 58 centres.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-05-20</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-proud-partner-uk-rcophth-national-ophthalmology-database">Alcon Proud Partner of UK RCOphth National Ophthalmology Database; Data Highlights Benefits of Specific AcrySof Models | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>a full 24 hours</h3></div>
          <div class="col-9">
            <p>Once Daily Relief Extra Strength is the first and only eye allergy itch relief drop offering a full 24 hours of relief without a prescription in the U.S. 1 The drop, formerly prescribed as Pazeo, joins Alcon’s over-the-counter ocular allergy portfolio to meet a variety of patient needs The expansion of the Pataday portfolio of products will strengthen Alcon’s leadership position in the U.S. eye allergy OTC market GENEVA--(BUSINESS</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2021-02-18</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-announces-broad-retail-availability-pataday-once-daily-relief-extra-strength-us">Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Clareon Vivity</h3></div>
          <div class="col-9">
            <p>{ text-decoration: underline } Clareon family of intraocular lenses (IOLs) delivers excellent vision, exceptional clarity and predictable refractive outcomes in a glistening-free § IOL material 1-3 Long-lasting clarity of the Clareon IOL and extensive real-world experience with excellent outcomes demonstrated in 30 peer-reviewed studies 4-6 Global rollout of Clareon portfolio has started; U.S. to launch Clareon Monofocal, Clareon PanOptix and Clareon Vivity IOLs in March with additional countries planned throughout 2022 GENEVA--(BUSINESS</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Clareon Toric</h3></div>
          <div class="col-9">
            <p>Clareon Monofocal and Clareon Toric IOLs have already been implanted in more than one million eyes across more than 70 countries. 15 Clareon IOLs are inserted using the next-generation, reusable Clareon Monarch ® IV Delivery System, which provides precise and controlled implantation and that was designed specifically for the new Clareon material.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
          <div class="row border-bottom mb-4">
          <div class="col-3"><h3>Doi</h3></div>
          <div class="col-9">
            <p>Doi: 10.2147/OPTH.S295008.</p>
            <table class="element table table-sm table-borderless text-muted mb-0" data-config='{ "type": "table", "limit": 1, "more": "↓ show more", "less": "↑ less", "number": true }'>
              <tbody>
                <tr>
                  <th scope="row">2022-03-07</th>
                  <td>3 mentions</td>
                  <td><a class="result-link" href="https://www.alcon.com/media-release/alcon-strengthens-leadership-iol-innovation-launch-clareon-portfolio-us">Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S. | Alcon.com</a></td>
                </tr>
    
              </tbody>
            </table>
          </div>
        </div>
  
        </div><!-- Outer col -->
    </div><!-- Container -->
    <!-- Option 1: Bootstrap Bundle with Popper -->
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.1.3/dist/js/bootstrap.bundle.min.js" integrity="sha384-ka7Sk0Gln4gmtz2MlQnikT1wXgYsOg+OMhuP+IlRH9sENBO0LRn5q+8nbTov4+1p" crossorigin="anonymous"></script>
  </body>
</html>
  